(Q30849078)

21 December 2017

title

Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy (English)

1 reference

21 December 2017

0 references

Chel Hun Choi

1

1 reference

21 December 2017

Sang Yong Song

2

1 reference

21 December 2017

Jung-Joo Choi

3

1 reference

21 December 2017

Young Ae Park

4

1 reference

21 December 2017

Heeseok Kang

5

1 reference

21 December 2017

Tae-Joong Kim

6

1 reference

21 December 2017

Jeong-Won Lee

7

1 reference

21 December 2017

Byoung-Gie Kim

8

1 reference

21 December 2017

Je-Ho Lee

9

1 reference

21 December 2017

Duk-Soo Bae

10

1 reference

21 December 2017

language of work or name

English

0 references

publication date

11 October 2008

1 reference

21 December 2017

published in

BMC Cancer

1 reference

21 December 2017

volume

8

1 reference

21 December 2017

page(s)

295

1 reference

21 December 2017

Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvan

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572070

Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572070

Is HIF-1alpha a pro- or an anti-apoptotic protein?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572070

Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572070

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572070

Regulation of angiogenesis via vascular endothelial growth factor receptors.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572070

The next frontier of molecular medicine: delivery of therapeutics.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572070

The Eugene M. Landis Award Lecture 1996. Delivery of molecular and cellular medicine to solid tumors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572070

Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-8-295

Vascular endothelial growth factor and prognosis of cervical carcinoma.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-8-295

Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572070

p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2572070

VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma

25 November 2018

1 reference

12 December 2020

Phase II study of neoadjuvant chemotherapy with mitomycin-c, vincristine and cisplatin (MVC) in patients with stages IB2-IIB cervical carcinoma

1 reference

12 December 2020

High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma

1 reference

12 December 2020

Vascular endothelial growth factor in cervical carcinoma

1 reference

12 December 2020

1 reference

12 December 2020

The association between vascular endothelial growth factor, microvessel density and clinicopathological features in invasive cervical cancer

1 reference

12 December 2020

Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma

1 reference

12 December 2020

Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer

1 reference

12 December 2020

Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas

1 reference

12 December 2020

Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix

1 reference

12 December 2020

Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-8-295

1 reference

21 December 2017

Dimensions Publication ID

0 references

1 reference

21 December 2017

PubMed publication ID

18847499

1 reference

21 December 2017